Playlist
President of Turkmenistan Serdar Berdimuhamedov has concluded his working visit to the United States, TDH reported.
Before departing from Washington, the head of state visited Andrews International Airport, where he congratulated Aksoltan Ataeva, Permanent Representative of Turkmenistan to the United Nations, on her birthday. The President also conveyed greetings and a bouquet of flowers on behalf of the National Leader of the Turkmen people, Gurbanguly Berdimuhamedov.
Upon arrival in Ashgabat, President Berdimuhamedov was welcomed by senior officials and representatives of state institutions.
Results of the “C5+1” Summit
Participation of the President of Turkmenistan in the “Central Asia – United States” summit reaffirmed the country’s commitment to the principles of positive neutrality and multilateral cooperation.
Turkmenistan views the “C5+1” format as an important mechanism for advancing both national and regional interests, promoting dialogue, and fostering stability and partnership.
The Turkmen side drew the attention of the international community to key issues such as transport connectivity, energy security, and environmental sustainability. Ashgabat continues to make a tangible contribution to addressing global challenges and strengthening its position as a transit and energy hub in the region.
During the visit, members of the Turkmen delegation also held a series of bilateral meetings, where they discussed issues of mutual interest and future cooperation prospects.
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz